ARYx Therapeutics have announced that its 5HT4 agonist ATI-7505 had demonstrated a favorable cardiotoxicity profile in a thorough QT study.
Filed under: Uncategorized | Tagged: 5-HT4, 5HT4, agonist, ATI-7505, ATI7505 | Leave a Comment »
Aryx announce favorable QT results with 5HT4 agonist ATI-7505
Posted on August 7, 2008 by crimsoncanary
Merck publish series of Bradykinin B1 Receptor Antagonists
Posted on August 7, 2008 by crimsoncanary
Merck have published a series of α-Hydroxy Amid Bradykinin B1 Receptor Antagonists
Filed under: Uncategorized | Tagged: antagonist, B1, Bradykinin, Bradykinin B1, Merck | Leave a Comment »
Merck publish series of Histamine H3 inverse agonists
Posted on August 7, 2008 by crimsoncanary
Merck have published a paperon the synthesis and evaluation of a Spiro-isobenzofuranone Histamine H3 Receptor Inverse Agonists
Filed under: Uncategorized | Tagged: agonist, Banyu, H3, Histamine, Histamine H3, Inverse, Merck | Leave a Comment »
